Kuyper Dirk 4
4 · CONMED CORP · Filed Apr 9, 2019
Insider Transaction Report
Form 4
CONMED CORPCNMD
Kuyper Dirk
Director
Transactions
- Tax Payment
Common Stock
2019-04-08$82.38/sh−482$39,707→ 14,018 total - Exercise/Conversion
Sars (Stock Appreciation Rights)
2019-04-08−1,000→ 0 totalExercise: $55.70From: 2016-06-01Exp: 2025-06-01→ Common Stock (1,000 underlying) - Tax Payment
Common Stock
2019-04-08$82.38/sh−406$33,446→ 13,500 total - Tax Payment
Common Stock
2019-04-08$82.38/sh−677$55,771→ 14,341 total - Exercise/Conversion
Common Stock
2019-04-08$39.64/sh+1,000$39,640→ 14,500 total - Sale
Common Stock
2019-04-08$83.39/sh−2,000$166,780→ 12,341 total - Exercise/Conversion
Sars (Stock Appreciation Rights)
2019-04-08−1,000→ 0 totalExercise: $39.64From: 2015-06-01Exp: 2024-09-11→ Common Stock (1,000 underlying) - Exercise/Conversion
Sars (Stock Appreciation Rights)
2019-04-08−1,000→ 0 totalExercise: $33.43From: 2014-06-01Exp: 2023-07-26→ Common Stock (1,000 underlying) - Exercise/Conversion
Common Stock
2019-04-08$33.43/sh+1,000$33,430→ 13,906 total - Exercise/Conversion
Common Stock
2019-04-08$55.70/sh+1,000$55,700→ 15,018 total
Footnotes (6)
- [F1]The exercise reported in this Form 4 was effected pursuant to a rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019.
- [F2]The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019.
- [F3]The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019.
- [F4]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 6, 2019.
- [F5]The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period.
- [F6]The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs generally vesting upon completion of the term of service.